Benzinga | Mar 11, 2021 04:24PM EST

Chembio Diagnostics Q4 EPS $(0.35) Misses $(0.28) Estimate, Sales $10.20M Beat $5.77M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 52.17 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $10.20 million which beat the analyst consensus estimate of $5.77 million by 76.78 percent. This is a 48.88 percent increase over sales of $6.85 million the same period last year.